XML 28 R19.htm IDEA: XBRL DOCUMENT v3.25.2

Segment Information (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Information Related to Statement of Operations

Schedule of Segment Information Related to Statement of Operations

		2025				2024				2025				2024
		Six months ended June 30,								Three months ended June 30,
		2025				2024				2025				2024
Revenue		$	689,680			$	802,972			$	129,904			$	489,594
Operating Expenses:
Employee compensation			599,072				515,686				312,560				268,776
Professional fees			132,657				114,114				44,757				50,964
Directors fees and expenses			227,107				121,306				107,107				1,065
Marketing and investor relations			79,002				97,241				48,756				47,119
Insurance**			91,544				98,383				45,355				46,009
Occupancy costs			42,132				30,147				20,615				14,735
Credit loss expense			124,253				-				124,253				-
Patent costs			27,117				34,196				15,313				14,454
Stock listing fees			35,000				32,750				17,500				16,375
Legal fees			1,070				27,975				1,070				3,390
Depreciation and amortization			5,723				7,422				2,864				3,718
Other operating expenses*			47,721				31,065				35,772				10,293
Operating expenses			1,412,398				1,110,285				775,922				476,898
Research and Development Expenses:
Employee compensation			90,643				80,050				43,280				33,344
Insurance**			89,635				95,799				44,425				44,903
Occupancy costs			127,796				90,446				63,252				44,197
Depreciation and amortization			443				5,530				223				2,785
Other research and development costs			23,446				6,746				17,906				3,601
Research and development expenses			331,963				278,571				169,086				128,830
Operating Loss		$	(1,054,681	)		$	(585,884	)		$	(815,104	)		$	(116,134	)

*	Other operating expenses and other research and development expenses consist principally of miscellaneous expenses, each of which is under the Company’s threshold to be separately presented as a significant expense.
**	Insurance includes all coverage including property, liability, directors’ and officers’ and employees’ medical.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration